You are viewing the public part of the archive. Login or request access to view more content.

Displaying 1-6 of 6 results
first frame of video
00:23:50

America and AIDS

This film tells the US story of the AIDS epidemic starting in the early 1980's. Scientists and activists, both pioneers and youths of today, talk about research, prevention, treatment and care. They also discuss stigma, homophobia and poverty as closely related to HIV and AIDS.

2007_america_and_aids_edited

first frame of video
00:11:47

Women at the Frontline of the AIDS Response

This film is about women from different parts of the world who are active in the HIV activist movement. They discuss gender inequality and the exposed situation of women and girls and explain the educational and empowering work which they are doing in their communities.

2006_women_at_the_frontline_of_the_aids_response

first frame of video
00:16:08

2006_4_03

In the last part of the interview with Dr Anthony Fauci he reflects on the global HIV/AIDS situation and response. He also compares AIDS to other diseases such as the Bird Flu, and discusses the specific social and socioeconomic factors of HIV/AIDS.

2006_4_03

first frame of video
00:19:27

2006_3_03

This is the third part of the interview with Dr Anthony Fauci. Here he talks about the American AIDS movement in the early 80's with activists such as the writer Larry Kramer in the frontline, and the time when he invited the leading activists up to his office.

2006_3_03

first frame of video
00:19:04

2003_8_01

French virologist and Nobel Prize winner Luc Montagnier reflects on the discovery of HIV, discusses disappointments and lessons learned along the way and the possibility of a vaccine, and gives advice for future AIDS researchers.

2003_8_01

first frame of video
00:44:42

2003_7_02

Sten Vermund from University of Alabama reflects on the history of the global AIDS epidemic and his involvement in the field as a young scientist in the 80's. He discusses the social and economic factors of HIV/AIDS, such as stigma, poverty and the drug industry.

2003_7_02